Clinical Trial Update: Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing safety and immune response of a Mammaglobin-A DNA vaccine in breast cancer patients receiving neoadjuvant endocrine ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mammaglobin-A DNA vaccine

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Cancer, Breast Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING